New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC From The Last 14 Days
Check below for free stories on AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
April 23, 2014
05:25 EDTNVSNovartis announces new data confirms efficacy of Gilenya
New analyses of pooled data from the FREEDOMS and FREEDOMS II trials will be presented at the 66th American Academy of Neurology, or AAN, Annual Meeting in Philadelphia, Pennsylvania, and will show the consistent efficacy of Gilenya on four key measures of multiple sclerosis disease activity - reducing relapses, new MRI lesion counts, brain volume loss and disability progression. Demonstrating benefit on these four measures is important in order to improve the course of MS and ultimately address the loss of function experienced by patients with MS. An additional analysis of FREEDOMS and FREEDOMS II will show that significantly more Gilenya-treated patients had brain volume loss rates comparable to people without MS. Given that brain volume loss, measured by MRI, starts early in the disease course and is correlated with long-term disability, a treatment benefit on this measure will be important for patients with MS.
April 22, 2014
18:42 EDTAAPLIcahn reiterates hasn't sold a share of Apple
Icahn speaks in online interview with CNBC's David Faber.
16:33 EDTNVSOn The Fly: Closing Wrap
Subscribe for More Information
16:04 EDTAAPLOptions Update; April 22, 2014
Subscribe for More Information
15:32 EDTGDNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Procter & Gamble (PG), consensus $1.02; Boeing (BA), consensus $1.56; Biogen Idec (BIIB), consensus $2.56; Dow Chemical (DOW), consensus 71c; EMC Corporation (EMC), consensus 35c; Thermo Fisher (TMO), consensus $1.40; Praxair (PX), consensus $1.51; General Dynamics (GD), consensus $1.64; Johnson Controls (JCI), consensus 65c; Norfolk Southern (NSC), consensus $1.15; Reynolds American (RAI), consensus 74c; Delta Air Lines (DAL), consensus 29c; Northrop Grumman (NOC), consensus $2.15; Air Products & Chemicals (APD), consensus $1.35; TD Ameritrade (AMTD), consensus 34c; Ingersoll-Rand (IR), consensus 26c; Dr Pepper Snapple (DPS), consensus 59c; Polaris Industries (PII), consensus $1.16; Ryder System (R), consensus 87c.
14:06 EDTAAPLApple's large screen phone may not emerge until 2015, Cnet reports
Subscribe for More Information
13:18 EDTAAPLOpera says Android overtook iOS in mobile ad traffic
Subscribe for More Information
12:39 EDTNVSOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday amid a number of big deals and a much talked about proposed deal in the pharmaceutical industry, as well as another wave of earnings reports. The market opened quietly but on the positive side of the ledger as investors pored over the multitude of quarterly reports issued after the close last night and earlier today. Near noon the market stood near its session highs and is pointing toward its sixth consecutive positive close. ECONOMIC EVENTS: In the U.S., existing home sales slipped 0.2% to a 4.59M rate in March, versus expectation for them to have fallen 1% to a 4.56M rate. The Richmond Fed manufacturing survey for April had a reading of 7, beating the consensus forecast for a reading of 2. COMPANY NEWS: Valeant Pharmaceuticals (VRX) teamed with Bill Ackman's hedge fund Pershing Square to make a hostile takeover offer for Allergan (AGN), sending shares of both companies higher. Allergan confirmed it received the offer of $48.30 in cash and 0.83 shares of Valeant stock for each of its own shares, which it said it will evaluate with the help of its advisers. Analysts' opinion on the fallout varied, with one firm suggesting Allergan could pursue its own takeover of Shire (SHPG) or Jazz Pharmaceuticals (JAZZ) as a defense, and another saying a rival big pharma company, such as Johnson & Johnson (JNJ) or Merck (MRK), could launch a competing bid for Allergan. Shares of Allergan led all gainers on the S&P 500, rising 16%, while Valeant shares gained more than 6%... A number of other big drug makers made news with a string of deals, as Novartis (NVS) and GlaxoSmithKline (GSK) both reshaped their companies via a trio of agreements. Novartis will acquire GSK's oncology products for a $14.5B payment and up to $1.5B contingent future payments, Novartis will sells its Vaccines business, excluding flu, to GSK for $7.1B plus royalties, and the two agreed to tie-up their consumer healthcare businesses through a joint venture. In a separate transaction, Novartis agreed to divest its Animal Health Division to Eli Lilly (LLY) for about $5.4B. MAJOR MOVERS: Among the notable gainers following their earnings reports were streaming video service Netflix (NFLX), which advanced almost 6%, and motorcycle maker Harley-Davidson (HOG), which rose 8%. Companies that slid following their earnings reports included printer maker Lexmark (LXK), which fell over 11%, and Pentair (PNR), which dropped almost 6%. INDEXES: Near midday, the Dow was up 106.77, or 0.65%, to 16,556.02, the Nasdaq was up 45.95, or 1.11%, to 4,167.50, and the S&P 500 was up 11.59, or 0.62%, to 1,883.48.
10:36 EDTNVSEli Lilly sees Novartis deal as accretive on a cash basis by 2016
Subscribe for More Information
10:02 EDTGDGeneral Dynamics awarded $32.7M contract modification by U.S. Navy
The U.S. Navy has awarded General Dynamics American Overseas Marine, or AMSEA, a $32.7M contract modification to operate and maintain seven large, medium-speed, roll-on / roll-off ships, or LMSR, for the Military Sealift Command. AMSEA is a wholly owned subsidiary of General Dynamics. Under the terms of the modification, AMSEA will provide services including crewing, engineering, maintenance, procurement and provisioning. Initially awarded in 2010, the contract has a potential value of $238M over seven years.
09:38 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:16 EDTNVSOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Netflix (NFLX), up 8%... Harley-Davidson (HOG), up 7%... PLX Technology (PLXT), up 8%... Illinois Tool (ITW), up 2.3%... Comcast (CMCSA), up 1%... McDonald's (MCD), up 0.6%. ALSO HIGHER: Allergan (AGN), up 17% after Valeant (VRX) confirms proposal to combine with the company for $48.30 and 0.83 shares of stock. Valeant is up 5% following its confirmation of the news that broke last night... GlaxoSmithKline (GSK), up 4.5% after agreeing to sell oncology products for $14.5B to Novartis (NVS) and buy Novartis' Vaccines business, currently excluding its flu business, for $7.1B plus royalties. Novartis shares trading in New York are also up 1% following the deals... Revance Therapeutics (RVNC), up 20% after announcing positive results from RT002 Phase 1/2 study... Facebook (FB), up 2% following upgrade at Credit Suisse. DOWN AFTER EARNINGS: Xerox (XRX), down 4%... Lexmark (LXK), down 4.8%. ALSO LOWER: Allison Transmission (ALSN), down 4% after filing to sell 25M shares for holders... FireEye (FEYE), down 2.9% after filing to sell 13.3M shares of common stock for holders... Bebe stores (BEBE), down 16% after reporting preliminary Q3 losses that were steeper than the consensus estimate.
07:50 EDTNVSNovartis CEO Jimenez says bolt-on-buys still could occur, Reuters says
Subscribe for More Information
07:48 EDTNVSGlaxoSmithKline to host conference call
Subscribe for More Information
07:46 EDTNVSGlaxo thinks Novartis agreement could mean future disposals, Reuters says
Subscribe for More Information
07:41 EDTNVSNovartis to host conference call
Subscribe for More Information
07:27 EDTBLKBlackRock names former HSBC employee senior strategist, Bloomberg says
Subscribe for More Information
07:26 EDTJPM, BLKInformation Management Network to hold a conference
Subscribe for More Information
07:25 EDTVIANatural E Creative Group to hold a summit
Subscribe for More Information
07:16 EDTAAPLiPhone sales could be hurt by fading phone subsidies, WSJ reports
Sales of Apple's (AAPL) iPhones may be further pressured as carriers make faster progress in transitioning customers away from subsidies, the Wall Street Journal reports. U.S. wireless carriers like T-Mobile US (TMUS) and AT&T (T) have been having more success than expected in moving customers to non-subsidy plans, a transition that could harm sales of expensive handsets such as the iPhone. Reference Link
07:11 EDTNVSEli Lilly to host conference call
Subscribe for More Information
06:42 EDTAAPLSamsung thinks $2.19B too costly for Apple patents, Bloomberg says
Samsung (SSNLF) feels that Apple's (AAPL) patent-infringement lawsuit of $2.19B is 57 times greater than what the South Korean company should pay if a jury deems that it infringed smartphone technology, reported Bloomberg. Reference Link
06:19 EDTJPMInvestment banks battling over stock trading, WSJ reports
Subscribe for More Information
05:38 EDTNVSEli Lilly acquires Novartis Animal Health for $5.4B in all-cash transaction
Subscribe for More Information
05:35 EDTNVSNovartis says transactions 'represent a transformation' for the company
The elements of the transaction with GSK (GSK) are inter-conditional and subject to approval by GSK shareholders. The Novartis (NVS) board unanimously believes that the transactions with GSK and the transaction with Lilly (LLY) are in the best interests of Novartis and the Novartis Shareholders as a whole. The transaction with Lilly is expected to close by the end of 1Q15 and the transaction with GSK is expected to close during the first half of 2015. The terms of the divestment of the Vaccines business would maximize the value of its pipeline, including Bexsero. The divestment of Animal Health would recognize the full value of the business. The transactions are expected to improve Novartis' sales and core operating income growth rates, while improving margins. Each of the transactions is projected to be value creating. The company commented, "These transactions represent a transformation for Novartis. We have leading positions in our core businesses in high-growth segments of healthcare. This will enable us to continue to build the world's most respected and successful healthcare company. Our strategic focus on science-based innovation and our global scale position the company well to meet the changes in the healthcare industry for the coming decade and beyond."
05:29 EDTNVSNovartis divests Animal Health Division to Eli Lilly for about $5.4B
Subscribe for More Information
05:26 EDTNVSNovartis OTC, GSK Consumer Healthcare form joint venture
Subscribe for More Information
05:23 EDTNVSNovartis divests Vaccines business to GSK for $7.1B
Novartis (NVS) has agreed to divest its Vaccines business to GSK (GSK), currently excluding its flu business, for $7.1B plus royalties. The $7.1B consists of $5.25B upfront and up to $1.8B in milestones. As a part of a value-maximization strategy in the context of the portfolio review, Novartis has initiated a separate sales process for its flu business.
05:20 EDTNVSNovartis to acquire GSK oncology products for $14.5B
Subscribe for More Information
April 21, 2014
16:01 EDTAAPLOptions Update; April 21, 2014
iPath S&P 500 VIX Short-Term Futures down 78c to 40.03. Option volume leaders: AAPL C GILD NFLX TSLA TWTR FB WLT according to Track Data.
15:05 EDTAAPLApple recruiting employees for mobile payments, Re/code says
Subscribe for More Information
14:40 EDTAAPLWi-LAN files appeal in patent suit with Apple
Wi-LAN (WILN) announced that it has filed an appeal with the United States Court of Appeals for the Federal Circuit in its patent dispute with Apple (AAPL) involving WiLAN's U.S. Patent No. RE37,802. On April 3, Judge Rodney Gilstrap of the U.S. District Court for the Eastern District of Texas, ruled that the Jury had no basis for invalidating the 802 patent at the trial of the WiLAN vs. Apple lawsuit in October 2013. In addition to this case, WiLAN is in litigation with Apple in the Southern District of California concerning the infringement of two patents related to LTE technology. WiLAN expects the case in Southern California to go to trial later this year if not settled earlier.
11:34 EDTAAPLApple April weekly volatility elevated at 50 into Q2
Subscribe for More Information
10:01 EDTMPCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:32 EDTAAPLJabil Circuit downgraded at RBC Capital
As noted earlier, RBC Capital downgraded Jabil Circuit (JBL) to Sector Perform from Outperform. As reasons for the downgrade, the firm cited concerns about Jabil circuit's largest customer, Apple (AAPL), as well as its belief that Jabil's FY15 guidance appears to reflect a best-case scenario. Target to $20 from $21.
08:40 EDTMPCMarathon Petroleum downgraded to Outperform from Focus List at Howard Weil
08:18 EDTNVSMomenta Pharma rises after high court rejects Copaxone delay bid
Shares of Momenta Pharmaceuticals (MNTA) are higher in pre-market trading after the Supreme Court denied Teva's (TEVA) request to delay the launch of generic forms of its relapsing-remitting multiple sclerosis product, Copaxone. WHAT'S NEW: Teva confirmed on April 19 that the Chief Justice of the United States denied the company's application for an injunction seeking to prevent the launch of a generic version of Copaxone. Teva will continue pursuing its appeal in the Supreme Court and defending its intellectual property for Copaxone, the company said. WHAT'S NOTABLE: Momenta has developed a generic version of Copaxone in partnership with Novartis' (NVS) Sandoz unit. Mylan, which is preparing to launch a generic version of Copaxone as well, said after the ruling: "We are pleased with the Chief Justice's decision, and we look forward to introducing the first generic Copaxone treatment for multiple sclerosis patients in the U.S. at market formation. Mylan remains eligible to receive approval from the U.S. FDA on May 25, 2014." PRICE ACTION: In pre-market trading, Momenta shares are up over 12% to $12.46, while Mylan shares are up more than 3% to $48.48. Teva shares trading in New York are down about 1.7% to $50 in pre-market trading.
07:46 EDTAAPLApple to add call credit payments in China, Marbridge Daily says
Subscribe for More Information
07:21 EDTNVSFDA Pediatric Advisory Committee to hold a meeting
The Committee discusses pediatric-focused safety reviews including MDT's Activa Dystonia Therapy, (BAX's Advate and Tisseel, NVS' Famvir, Tibotec's (JNJ subsidiary) Intelence, UCB Pharma's Keppra, MRK's Maxalt, BAYRY's Natazia, Digestive Care's Pertzye, JNJ's Prezista, BMY's Reyataz, SNY's Sklice, PFE's Torisel, Aptalis' Ultresa, and GILD's Viread in a meeting being held in Bethesda, Maryland on April 21 at 8 am. Webcast Link
06:48 EDTAAPLMicrosoft faces internal & external conflicts in three segments, DigiTimes says
Subscribe for More Information
06:45 EDTAAPLApple and Google compete to offer exclusive game apps, WSJ reports
Subscribe for More Information
06:37 EDTAAPLSquare discusses possible sale as losses widen, WSJ reports
Mobile-payments startup Square discussed a possible sale to several rivals as its losses widen, reports the Wall Street Journal, citing people familiar with the matter. Google (GOOG) discussed a possible acquisition of the company earlier this year, but it was not clear if the talks were continuing. Square also had discussions about a deal with Apple (AAPL) and eBay's (EBAY) PayPal. Reference Link
06:27 EDTAAPLApple revenue outlook likely to miss expectations, says Piper Jaffray
Subscribe for More Information
06:26 EDTAAPLCourt documents say Silicon Valley giants discussed hiring, WSJ says
Google (GOOG), Apple (AAPL), Intel (INTC) and Adobe (ADBE had colluded with one another to supress wages between 2005 and 2009, reports the Wall Street Journal, citing documents from an antitrust case. The companies had agreed not to poach each other's employees among other things. The companies had also tried to bring Facebook (FB) on board, but Facebook rejected the offer. Reference Link
April 17, 2014
12:00 EDTBKSBarnes & Noble falls 11.2%
Barnes & Noble is down 11.2%, or $2.08, to $16.52
10:27 EDTJPMJPMorgan looks to technology startup apps to plan mobile future, Bloomberg says
When it came time to update its mobile banking app, JPMorgan's (JPM) digital chief Gavin Michael studied software created by technology startups, such as Uber and GrubHub's (GRUB) Seamless, for inspiration to give the app a more "simple, human, cohesive" design, according to Bloomberg, citing comments from Michael. Reference Link
10:00 EDTBKSBarnes & Noble falls 8.2%
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOGL GOOG NFLX TSLA AMZN GOLG NOV AA IBM
08:58 EDTBKSOn The Fly: Pre-market movers
Subscribe for More Information
08:46 EDTBKSBarnes & Noble 3.7M share Block Trade priced at $18.30
Morgan Stanley acted as sole book running manager for the offering.
08:31 EDTBKSBarnes & Noble Chairman Riggio says sold 3.7M shares of stock
Subscribe for More Information
07:49 EDTBLKBlackRock given direct access to invest directly in China markets, Reuters says
BlackRock said it had been granted a license to invest directly in China's mainland capital markets, which will give investors some access to the country's stock and bond markets, Reuters reported yesterday. Reference Link
07:21 EDTAAPLApple April weekly volatility elevated at 38 into Q2
Subscribe for More Information
06:55 EDTAAPLApple plans to launch song-ID feature for iOS software, Bloomberg says
Subscribe for More Information
06:44 EDTJPMBank of America to pay $950M to settle mortgage allegations, NY Times says
Subscribe for More Information
06:41 EDTBLKBlackRock reports assets under management $4.4T
Subscribe for More Information
06:39 EDTBLKBlackRock raises quarterly dividend by 15% to $1.93 per share
Subscribe for More Information
06:39 EDTBLKBlackRock: Fixed income landscape undergoing significant change
Subscribe for More Information
06:33 EDTBLKBlackRock reports Q1 adjusted EPS $4.43, consensus $4.14
Subscribe for More Information
06:31 EDTJPMBig banks boosting their business lending, WSJ reports
Subscribe for More Information
April 16, 2014
17:57 EDTAAPLYahoo seeks default search status for Apple products, Re/code says
Subscribe for More Information
16:00 EDTAAPLOptions Update; April 16, 2014
Subscribe for More Information
15:17 EDTBLKNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include General Electric (GE), consensus 32c; Philip Morris (PM), consensus $1.16; Schlumberger (SLB), consensus $1.20; PepsiCo (PEP), consensus 75c; Union Pacific (UNP), consensus $2.37; UnitedHealth (UNH), consensus $1.09; Honeywell (HON), consensus $1.26; Goldman Sachs (GS), consensus $3.44; du Pont (DD), consensus $1.59; Morgan Stanley (MS), consensus 60c; Danaher (DHR), consensus 80c; BlackRock (BLK), consensus $4.14; Blackstone (BX), consensus 55c; Chipotle Mexican Grill (CMG), consensus $2.86; Mattel (MAT), consensus 9c; Snap-on (SNA), consensus $1.54; AutoNation (AN), consensus 74c.
13:51 EDTNVSAlnylam COO critical of big pharma, FierceDrugDelivery reports
After Novartis (NVS) decided to end its RNAi research, Alnylam COO Barry Greene told FierceDrugDelivery that big pharma has "never been able to innovate." Greene attributes the recent sell-off in Alnylam shares to "generally bearish sentiment on Wall Street regarding biotech stocks in particular." Reference Link
11:19 EDTNVSNovartis launches new eye care products facility in Singapore, Nikkei says
Subscribe for More Information
11:02 EDTAAPLApple slips lower, levels to watch
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:17 EDTJPMHigher One appoints Sheinbaum CEO
Subscribe for More Information
08:46 EDTAAPLApple risk/reward looks positive into Q2 results, says Pacific Crest
Pacific Crest thinks that Apple's low valuation should prevent it from falling sharply, and it expects the company's Q2 iPhone sales to exceed expectations. The firm believes that iPhone 6 can enable the company to return to growth, and recommends buying the stock. .
08:35 EDTAAPLLiveDeal completes development of iOS mobile app
Subscribe for More Information
07:51 EDTAAPLApple denied motion to dismiss e-books suit, Reuters says
Subscribe for More Information
07:45 EDTAAPLApple earnings have more downside risk than upside risk, says Bernstein
Subscribe for More Information
07:40 EDTAAPLGoogle Play Q1 downloads exceeded downloads from Apple store, App Annie says
Subscribe for More Information
07:12 EDTVIA, VIABBSkyB, Discovery make joint offer for Channel 5, Bloomberg says
Subscribe for More Information
06:52 EDTAAPLSamsung objects to Apple's patent claims in $2B court battle, Bloomberg says
Subscribe for More Information
06:32 EDTBLKGoldman Sachs tries to jump start stock-trading business amid concerns, WSJ says
Subscribe for More Information
April 15, 2014
16:00 EDTAAPLOptions Update; April 15, 2014
Subscribe for More Information
09:49 EDTJPMJPMorgan reports March net credit losses 3.07% vs. 2.82% last month
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:54 EDTBLKBlackRock April volatility elevated at 38 into Q4 and outlook
Subscribe for More Information
07:51 EDTGDGeneral Dynamics chooses to skip GAO protest over Army car plan, Reuters says
General Dynamics (GD) said it would not ask the congressional Government Accountability Office to rule on a U.S. Army vehicle competition that it says is skewed to favor its rival, Britain's BAE Systems (BAESY), according to Reuters, citing a statement from a General Dynamics spokesman. The spokesman said, "We will continue to discuss the AMPV program with the U.S. Department of Defense and the Congress. We do not believe a GAO protest is the right forum for this issue and we will not file one." Reference Link
07:46 EDTAAPLMonitor says Apple antitrust compliance off to 'promising start,' Reuters says
Subscribe for More Information
07:35 EDTNVSAlnylam outlook not affected by Novartis decision, says JMP Securities
Subscribe for More Information
07:28 EDTBLKSEC officials weighing curbs on trading fees, WSJ says
SEC officials, including some commissioners, are considering a trial program to curb "maker-taker" fee plans that are a major source of revenue for exchanges and some high-frequency trading firms, according to The Wall Street Journal. Fund managers, including BlackRock (BLK), are concerned about the negative effects of maker-taker, the report added. IntercontinentalExchange (ICE) CEO Jeffrey Sprecher, along with representatives from T. Rowe Price (TROW) and from RBC Capital (RY), recently held a series of private meetings with SEC Chairman Mary Jo White to push for its elimination, according to the report, citing people familiar with the matter. Like IntercontinentalExchange, which owns the New York Stock Exchange, Nasdaq (NDAQ) is a publicly-traded exchange operator. Reference Link
07:22 EDTNVSNovartis to Shire said to mull offers for ThromboGenics, Bloomberg says
Subscribe for More Information
06:36 EDTNVSRanbaxy inspection failures add $900M to heart drug costs, Bloomberg says
A gap in U.S. patent law has kept cheap copies of Novartis' (NVS) heart drug Diovan off the market for 18 months, which has cost U.S. consumers and insurers as much as $900M in possible savings, reported Bloomberg. Ranbaxy (RBXLY) is the only company permitted to sell a generic version of Diovan, and hasn’t been able to manufacture and market them after four factories it runs in India failed U.S. inspections. Reference Link
06:32 EDTNVSPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
06:08 EDTAAPLSamsung: Gains in smartphone market the result of strategy shift, WSJ reports
Subscribe for More Information
April 14, 2014
16:00 EDTAAPLOptions Update; April 14, 2014
iPath S&P 500 VIX Short-Term Futures down 32c to 44.41. Option volume leaders: AAPL C GILD TSLA LNG NQ BAC ZNGA according to Track Data.
14:42 EDTNVSAlnylam slips after Novartis reportedly cuts back RNAi development
Subscribe for More Information
11:48 EDTNVSNovartis significantly reducing RNAi development efforts, FierceBiotech says
Subscribe for More Information
10:56 EDTJPMMasterCard, Visa rise after analysts recommend their shares
Subscribe for More Information
10:03 EDTGDGeneral Dynamics Canada to provide sonar system upgrades to Portuguese Navy
General Dynamics Canada is installing an adjunct processing system on three VASCO DA GAMA-class frigates of the Portuguese Navy. Designed by General Dynamics Canada, the ECLIPSE adjunct processor provides the in-service AN/SQS-510 sonar systems with enhanced operational capability to detect submarines and torpedoes.
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:05 EDTJPMJPMorgan valuation still attractive, says Wells Fargo
Subscribe for More Information
07:54 EDTAAPLApple in talks for $100 iPhone 6 price increase, says Jefferies
Subscribe for More Information
07:08 EDTJPMJPMorgan has good value for patient investors, says Bernstein
After JPMorgan reported weaker than expected Q1 results, Bernstein reduced its 2014 EPS estimate for the company to $5.50 from $5.80. However, the firm thinks the company could benefit from higher interest rates, while its valuation is attractive. Bernstein keeps an Outperform rating on the stock.
07:06 EDTAAPLU.S. Geospatial Intelligence Foundation to hold a symposium
GEOINT 2013 Symposium, originally scheduled for October 2013, is being held in Tampa, Florida on April 14-17.
06:50 EDTAAPLChecks show Apple not developing basebands, says Deutsche Bank
Deutsche Bank says that despite recent press reports, its industry checks show that Apple (AAPL) is not developing its own baseband chipset. Deutsche believes Apple likely seeking better integration with existing baseband chipsets or possibly developing its own internal WiFi chipset. The firm thinks Qualcomm's (QCOM) long term prospects remain intact and it reiterates a Buy rating on the stock with an $86 price target.
06:40 EDTAAPLNo lines for Samsung's Galaxy S5 but carriers say demand healthy, Re/code says
Subscribe for More Information
06:11 EDTAAPLIntel works with HzO to enhance water resistance in products, DigiTimes says
Subscribe for More Information
April 11, 2014
17:28 EDTJPMJPMorgan outlook promising despite earnings shortfall, Barron's reports
Despite JPMorgan's stock falling 3.5% in today's trading after a tough quarter where the bank fell short of "already dim" projections, the bank's outlook is "promising" and the bank "should reward patience," according to Barron's "Barron's Take" column. Reference Link
17:09 EDTJPMStocks tumble as investors remain skittish
Subscribe for More Information
16:21 EDTJPMOn The Fly: Closing Wrap
Stocks on Wall Street were lower in a session that saw the averages struggle for direction early before sellers gained control and pushed stocks lower through the second half of the session. With today's losses, the averages each finished the week with losses greater than 2%, with the tech-heavy Nasdaq losing 3% to close below 4,000 for the first time since early February. ECONOMIC EVENTS: In the U.S., the Producer Price Index jumped 0.5% in March, versus expectations for it to be up 0.1%. The University of Michigan consumer sentiment reading jumped to 82.6 in the preliminary April look, which was better than forecast and its highest reading since July. COMPANY NEWS: JPMorgan (JPM) and Wells Fargo (WFC) kicked off earnings season for the major banks, with their quarterly results, and stocks, moving in opposite directions following the news. Dow member JPMorgan fell $2.10, or 3.66%, to $55.30 after its earnings per share and revenue significantly trailed consensus estimates. Shares of Wells gained 37c, or 0.78%, to $48.08 after the bank's profits beat the consensus forecast. MAJOR MOVERS: Among the notable gainers was BofI Holding (BOFI), up $6.02, or 8.09%, to $80.46 near midday after the company last night announced a deal to acquire H&R Block's (HRB) bank assets. H&R Block shares fell 78c, or 2.74%, to $27.64. Also higher was Zygo (ZIGO), up $4.75, or 32.36%, to $19.43 after the company agreed to be acquired by Ametek (AME) for $19.25 per share in cash in a deal that represents an aggregate enterprise value of $280M for Zygo. Among the noteworthy losers was Herbalife (HLF), down $8.36, or 13.97%, to $51.48 after a report late in the session from the Financial Times said the company is facing a criminal investigation from the U.S. Department of Justice and FBI regarding its business practices. Also lower was NQ Mobile (NQ), a recent target of noted short-seller Carson Block, down $3.29, or 20.58%, to $12.70 after its profit missed expectations and the company disclosed that it found accounting errors in its recent reports. INDEXES: The Dow was down 143.47, or 0.89%, to 16,026.75; the S&P 500 was down 17.39, or 0.95%, to 1,815.69; the Nasdaq was down 54.37, or 1.34%, to 3,999.73.
13:01 EDTJPMOn The Fly: Midday Wrap
Stocks on Wall Street were lower again at midday, with the Dow being weighed on by a disappointing earnings report from banking giant JPMorgan (JPM). The reports from JPMorgan and peer Wells Fargo (WFC) certainly seemed to have more of an impact on market sentiment than the better than expected University of Michigan consumer confidence reading. ECONOMIC EVENTS: In the U.S., the Producer Price Index jumped 0.5% in March, versus expectations for it to be up 0.1%. The University of Michigan consumer sentiment reading jumped to 82.6 in the preliminary April look, which was better than forecast and its highest reading since July. COMPANY NEWS: JPMorgan and Wells Fargo kicked off earnings season for the major banks, with their stocks moving in opposite directions to mirror their earnings results. Dow member JPMorgan slipped more than 3% after its earnings per share and revenue significantly trailed consensus estimates, while Wells shares gained about 1.5% after the bank's profits beat the consensus forecast. Both noted, however, that their capital levels continued to strengthen during the quarter and both gave optimistic views on their ability to continue to reduce expenses. MAJOR MOVERS: Among the notable gainers was BofI Holding (BOFI), which rose 11% near midday after the company last night announced a deal to acquire H&R Block's (HRB) bank assets. H&R Block shares were down over 2% near noon. Also higher was mobile game maker Zynga (ZNGA), whose shares gained almost 3% after the company announced a new CFO and the stock was upgraded to Equal Weight by analysts at Morgan Stanley. Another gainer, Zygo (ZIGO), jumped 31% after the company agreed to be acquired by Ametek (AME) for $19.25 per share in cash in a deal that represents an aggregate enterprise value of $280M for Zygo. Shares of Ametek also rose 1.5% following the deal announcement. Among the noteworthy losers was 3D-printer maker Voxeljet (VJET), which fell 16% after its 3-million-share secondary offering of common stock priced at $15.00. Also lower was NQ Mobile (NQ), a recent target of noted short-seller Carson Block, which dropped over 13% after its profit missed expectations and the company disclosed that it found accounting errors in its recent reports. INDEXES: Near midday, the Dow was down 81.88, or 0.51%, to 16,088.34, the Nasdaq was down 15.30, or 0.38%, to 4,038.80, and the S&P 500 was down 6.89, or 0.38%, to 1,826.19.
12:12 EDTAAPLApple April weekly volatility elevated at 34 into Q2
Apple 4/25/14 weekly call option implied volatility is at 34, May is at 25, June is at 23, October at 21; compared to its 26-week average of 26 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on April 23.
10:19 EDTAAPLApple drops to session lows, levels to watch
Subscribe for More Information
09:37 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:31 EDTJPMJPMorgan CEO Dimon says bank 'one of the good guys' in 'Flash Boys'
Subscribe for More Information
09:26 EDTJPMJPMorgan falls after results, levels to watch
Subscribe for More Information
09:13 EDTJPMOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Fastenal (FAST), up 3%... Wells Fargo (WFC), up 0.2%. ALSO HIGHER: H&R Block (HRB), up 5% after announcing a deal for BofI (BOFI) to acquire H&R Block's bank assets. Bofi up 9.4% after the deal announcement... Zynga (ZNGA), up 1.7% after naming new CFO, shares upgraded to Equal Weight at Morgan Stanley... SINA (SINA), up 2% after announcing up to $500M share repurchase program. DOWN AFTER EARNINGS: JPMorgan (JPM), down 3.7%... NQ Mobile (NQ), down 14.6%. ALSO LOWER: Gap (GPS), down 4% after reporting March SSS fell 6%, shares downgraded at Janney Capital... Voxeljet (VJET), down 16% after 3M share secondary offering priced at $15.00... Datawatch (DWCH), down 29% after cutting its second quarter revenue outlook.
09:03 EDTJPMJPMorgan sees core margin to be 'relatively stable' throughout 2014
JPMorgan CFO Marianne Lake said the bank expects its core margin to be "relatively stable" throughout 2014 and to be "relatively stable to positive" in 2015.
08:53 EDTJPMJPMorgan weakness a buying opportunity, says BofA/Merrill
Subscribe for More Information
08:47 EDTJPMJPMorgan CFO says environment for M&A remains 'robust'
Subscribe for More Information
08:45 EDTJPMJPMorgan CFO Lake says bank lost share in mortgages
Subscribe for More Information
08:35 EDTJPMJPMorgan CFO says reported net income 'very close' to being core result
Says no one-time or non-recurring impacts to quarter were significant enough to be communicated as adjustments in earnings press release. JPMorgan CFO Marianne Lake speaking on Q1 earnings conference call.
08:32 EDTJPMJPMorgan sees adjusted expense to be below $59B for 2014
JPMorgan expects Treasury and CIO NII to break-even during the second half of 2014. The bank expects adjusted expense to be below $59B for 2014. JPMorgan is targeting Basel III Tier 1 common ratio of 10%+, with a Firm SLR target of 5.5%+/- and a Bank SLR target of 6%+.
08:29 EDTJPMJPMorgan: card releases 'essentially done,' potential for more mortgage releases
Subscribe for More Information
08:02 EDTAAPLApple Q1 should be in line but slight risk to Q2, says Cowen
Subscribe for More Information
07:52 EDTJPMManhattan federal prosecutors probe JPMorgan's Masters, Bloomberg says
Subscribe for More Information
07:32 EDTJPMJPMorgan's Masters aimed to keep CEO position in sale, Bloomberg says
Subscribe for More Information
07:27 EDTJPMFutures indicate market slide may continue
Stock futures are suggesting another lower as the market appears ready to extend its slide. Any help investors expected from earnings reports from JP Morgan (JPM) were dashed when the company missed Wall Street estimates. Investors will be watching economic data today, including the producer price index and the University of Michigan's consumer confidence report.
07:18 EDTJPMJPMorgan down 1.6% in pre-market trading after Q1 report
07:13 EDTJPMJPMorgan reports Q1 mortgage application volumes down 57% from prior year
Subscribe for More Information
07:10 EDTJPMJPMorgan CEO Dimon has 'growing confidence' in economy
Subscribe for More Information
07:07 EDTJPMJPMorgan Q1 Basel III Tier 1 common ratio 9.5%
Subscribe for More Information
07:06 EDTJPMJPMorgan Q1 headcount down 8,904 from prior year to 246,994
Subscribe for More Information
07:06 EDTJPMJPMorgan reports Q1 provision for credit losses $850M
Subscribe for More Information
07:04 EDTJPMJPMorgan board authorizes firm to repurchase $6.5B of common equity
The board authorized the firm to repurchase $6.5B of common equity commencing within Q2 this year through the end of the first quarter of 2015. During the first quarter of 2014, the Firm repurchased $400M of common equity. The Federal Reserve Board informed the Firm that it does not object to the Firm’s proposed 2014 capital distribution plan.
07:03 EDTJPMJPMorgan reports Q1 Consumer and Community Banking revenue $10.46B
Subscribe for More Information
07:03 EDTJPMJPMorgan board increases quarterly dividend to 40c from 38c
Subscribe for More Information
07:01 EDTJPMJPMorgan reports Q1 Basel 1 Tier 1 Capital Ratio 12.1%
Subscribe for More Information
07:01 EDTJPMJPMorgan reports Q1 EPS $1.28, consensus $1.40
Subscribe for More Information
07:00 EDTJPMJPMorgan reports Q1 EPS $1.28, consensus $1.40
Reports Q1 revenue $22.99B, consensus $24.53B
06:47 EDTAAPLSamsung ups S5 incentives to fend off rivals, Bloomberg says
Subscribe for More Information
06:46 EDTAAPLDocuments: Samsung misled investors about Galaxy tablet sales, Fotune says
According to documents revealed in the Samsung (SSNLF)-Apple (AAPL) lawsuit, Samsung misled the public about how many tablets it sold in 2011, Fortune reports. Strategy Analytics told the world Samsung sold 2M Galaxy Tablets in six weeks, when "it took Samsung all of 2011 to sell half that many." Reference Link
06:28 EDTAAPLApple: iOS, OSX not affected by Heartbleed flaw, Re/code reports
Subscribe for More Information
06:05 EDTAAPLReport: Apple may offer high-res iTunes tracks in 2 months, Apple Insider says
Apple may plan to offer high-resolution 24-bit tracks on iTunes some time in the next few months, reports Apple Insider. Blogger Robert Hutton, citing an unnamed source, said Apple will charge an additional dollar for the high-resolution tracks. Reference Link
06:03 EDTJPMJPMorgan CEO Jamie Dimon hopes to minimize corporate cash, WSJ says
Subscribe for More Information
April 10, 2014
16:00 EDTAAPLOptions Update; April 10, 2014
Subscribe for More Information
15:25 EDTJPMNotable companies reporting before tomorrow's open
Subscribe for More Information
13:43 EDTBLKFidelity to pitch new lost cost trading venue to large asset managers, WSJ says
Fidelity is working on a new trading venue, dubbed "Sakura," that it hopes will be a collaboration among big mutual-fund firms to reduce costs and streamline trading and will be an improvement over other "dark pools," reported The Wall Street Journal, citing people with knowledge of the matter. The report said Fidelity is in the initial planning stages and has just started pitching the idea to other large asset managers. Publicly traded fund managers include BlackRock (BLK), Franklin Resources (BEN) and T. Rowe Price (TROW), while Investment Technology Group (ITG) currently operates dark pools that facilitate block trading among large institutions. Exchange operators Nasdaq (NDAQ) and Intercontinentalexchange's (ICE) NYSE have previously testified to legislators that too much trading occurs in dark pools, hurting investors. Reference Link
13:33 EDTJPMEarnings Preview: Analysts mixed on JPMorgan into Q1 results
Subscribe for More Information
13:08 EDTJPMJP Morgan April weekly 58 straddle priced for 2% move into Q1
Subscribe for More Information
10:03 EDTGDGeneral Dynamics awarded $23M by Space and Naval Warfare Systems Command
General Dynamics Information Technology has been awarded the Joint Effects Model Increment 2 contract by the Space and Naval Warfare Systems Command. The cost plus fixed-fee award has a potential value of $23.5M over five years if all options are exercised. Under this contract, General Dynamics will develop software that will serve as the foundation for the JEM Increment 2 System as well as the software architecture for the JEM science and technology prototype.
10:00 EDTAAPLOn The Fly: Analyst Initiation Summary
Apple (AAPL) initiated with a Buy at Deutsche Bank... Crocs (CROX) initiated with a Buy at Buckingham... Deckers Outdoor (DECK) initiated with a Buy at Buckingham... EMC (EMC) initiated with a Buy at Deutsche Bank... HP (HPQ) initiated with a Buy at Deutsche Bank... IBM (IBM) initiated with a Hold at Deutsche Bank... NeoPhotonics (NPTN) coverage resumed with a Market Perform at Raymond James... NetApp (NTAP) initiated with a Hold at Deutsche Bank... Nutrisystem (NTRI) initiated with a Buy at B. Riley... Questar (STR) initiated with an Underperform at BofA/Merrill... S&T Bancorp (STBA) initiated with an Outperform at Raymond James... STB Systems Inc (STBI) initiated with an Outperform at Raymond James... Skechers (SKX) initiated with an Underperform at Buckingham... Steven Madden (SHOO) initiated with a Buy at Buckingham... UGI Corporation (UGI) initiated with a Buy at BofA/Merrill... Web.com (WWWW) initiated with a Neutral at Buckingham... Ally Financial (ALLY) initiated with a Buy at BTIG... Visteon (VC) initiated with a Buy at Citigroup... Greatbatch (GB) initiated with a Buy at KeyBanc... Steris (STE) initiated with a Buy at KeyBanc... Cooper Companies (COO) initiated with a Hold at KeyBanc... Hill-Rom (HRC) initiated with a Hold at KeyBanc... Invacare (IVC) initiated with a Hold at KeyBanc... Teleflex (TFX) initiated with a Hold at KeyBanc... Provident Financial (PROV) initiated with a Market Perform at Keefe Bruyette... UMH Properties (UMH) initiated with a Hold at Wunderlich.
09:37 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: SIRI RAD AAPL AMZN AA FB TSLA MRK CVX C
08:37 EDTJPMDimon admits JPMorgan had 'tin ear' when listening to regulators, Reuters says
JPMorgan CEO Jamie Dimon said the company had a “tin ear” when dealing with regulators before settling investigations into mortgage lapses and trading losses, according to Reuters, citing comments from Dimon in a letter to the bank's investors. Dimon said, "Our response generally was, ‘We know what we’re doing.' Well, we should have done more self-examination. We need to be better listeners.” Reference Link
08:22 EDTAAPLApple seen offering iWatches priced as high as 'thousands,' AppleInsider says
KGI analyst Ming-Chi Kuo, who has a proven track record of predicting about Apple hardware, predicts that one of the major differences between Apple's smartwatch and those from rivals will be that its casing and band will come in a variety of materials and that luxury iWatches will carry a price tag of "several thousand dollars," reported AppleInsider. Other features expected by Kuo for the device, including biometrics, a flexible AMOLED display with sapphire cover lens and NFC, the report added. Reference Link
07:43 EDTJPMJPMorgan (JPM) CEO says 2013 was a year of 'pain,' WSJ reports
J.P. Morgan CEO Jamie Dimon acknowledged in his annual shareholder letter that legal issues and new regulations faced by the bank made 2013 "the most painful, difficult and nerve-wracking experience" he has ever dealt with professionally, reported The Wall Street Journal. Reference Link
07:39 EDTAAPLApple Chief Designer gains more say over software, Bloomberg says
Subscribe for More Information
07:24 EDTAAPLApple may release 12" Retina MacBook Air, low price iMac in 2014, MacRumors says
Subscribe for More Information
06:48 EDTAAPLApple initiated with a Buy at Deutsche Bank
Deutsche Bank believes the iPhone and iPad offer good growth for Apple with upside coming from the potential for a larger screen sized phone. The firm initiated the stock with a Buy rating and $650 price target.
06:41 EDTAAPLApple confirms Christie departure, FT reports
Subscribe for More Information
06:41 EDTJPMGo Daddy hires Morgan Stanley, JPMorgan for IPO, NY Times says
Subscribe for More Information
06:35 EDTJPMMobile banking presents opportunity and risks for banks, WSJ reports
Subscribe for More Information
April 9, 2014
17:26 EDTAAPLGartner says worldwide PC shipments in Q1 fell 1.7%
Subscribe for More Information
16:00 EDTAAPLOptions Update; April 9, 2014
Subscribe for More Information
15:56 EDTAAPLApple interface head rumored to be exiting, AppleInsider says
Subscribe for More Information
15:21 EDTAAPLApple weighing 'dramatic' overhaul of iTunes store, Billboard says
Subscribe for More Information
13:45 EDTBKSBarnes & Noble rises after report says Nook spin may now be more feasible
Subscribe for More Information
13:09 EDTBKSBarnes & Noble shares up more than 3% after reports company will spin-off Nook
Subscribe for More Information
10:39 EDTAAPLJudge says certain WiLAN patent claims are valid in litigation vs. Apple
Subscribe for More Information
10:39 EDTAAPLLogitech has risk of increasing competition from Apple, says UBS
UBS notes that Apple (AAPL) filed a patent with the USPTO for an electronic device/tablet cover that seems to include a keyboard. UBS believes Apple could introduce its own branded keyboard cover, and other branded peripherals, in order to grab market share from its highly loyal consumer base. The analyst believes competition for Neutral rated Logitech (LOGI) will accelerate, significantly impacting growth prospects.
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:24 EDTAAPLGoogle, Apple have considered acquiring Square, Re/code reports
Subscribe for More Information
07:54 EDTAAPLSamsung, Apple pushed to make high-end phones less costly, Reuters says
Subscribe for More Information
07:51 EDTJPMJP Morgan April volatility up into Q1 and outlook
Subscribe for More Information
07:50 EDTJPMCEO Dimon says U.S. banking system 'sound,' Europe lagging, Reuters says
Subscribe for More Information
07:28 EDTAAPLAmazon looking to court game developers for Fire TV, NY Post reports
Subscribe for More Information
07:18 EDTJPMLevy Economics Institute to hold a conference
Subscribe for More Information
07:09 EDTNVSReckitt Benckiser may be frontrunner for Merck unit, Bloomberg reports
Subscribe for More Information
06:35 EDTJPMRegulators increase leverage ratio requirement for large banks, NY Times says
Subscribe for More Information
06:27 EDTJPMBig banks must add capital to comply with new rules, WSJ reports
A of January 1, 2018, the U.S.'s eight largest banks -- including Citigroup (C), JPMorgan (JPM) and Goldman Sachs (GS) -- must add up to $68B in extra capital to comply with a new rule intended to help firms weather losses during periods of market stress, the Wall Street Journal. The banks will be required to maintain well above the minimum levels of capital held against assets on their books. Banks must report the new levels next year. Reference Link
06:18 EDTAAPLApple seeks $2.2B in damages from Samsung in patent infringement, WSJ says
Subscribe for More Information
06:15 EDTAAPLFlexible PCB samples delivered for Apple iWatch validation, DigiTimes says
Flexible PCB suppliers have reportedly delivered FPCB samples for use in Apple's iWatch devices for validation, reports DigiTimes. According to industry sources, Apple is expected to unveil the iWatch wearable devices in September. Reference Link
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use